Literature DB >> 6845218

Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations.

J Michaelis, H Michaelis, E Glück, S Koller.   

Abstract

From 1964 to 1976, a cohort study was performed in West Germany to study the possible influence of various factors on pregnancy and child development. Results of the evaluation of 13,643 pregnancies are given with respect to possible teratogenetic effects of antiemetic drugs and sex hormones administered in early pregnancy. There was no evidence of an increased risk of major malformations following the intake of certain antiemetic drugs and progesterone. Also, the use of a hormonal pregnancy test was not significantly associated with an increase of major malformations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845218     DOI: 10.1002/tera.1420270109

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  13 in total

Review 1.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2017-10-31

Review 2.  The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.

Authors:  Fatma Etwel; Lauren H Faught; Michael J Rieder; Gideon Koren
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

3.  The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.

Authors:  Mahmoud Zaqout; Emad Aslem; Mazen Abuqamar; Osama Abughazza; Joseph Panzer; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2015-05-15       Impact factor: 1.655

Review 4.  Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2014-09-23       Impact factor: 3.300

5.  Bendectin: the wrong way to regulate drug availability.

Authors:  J S Leeder; S P Spielberg; S M MacLeod
Journal:  Can Med Assoc J       Date:  1983-11-15       Impact factor: 8.262

6.  In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.

Authors:  Caitlin C Murphy; Piera M Cirillo; Nickilou Y Krigbaum; Barbara A Cohn
Journal:  Am J Obstet Gynecol       Date:  2021-11-09       Impact factor: 10.693

7.  Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.

Authors:  Steve N Caritis; Shringi Sharma; Raman Venkataramanan; Gary D Hankins; Menachem Miodovnik; Mary F Hebert; Jason G Umans; Thomas Benedetti; Donald Mattison; Anne Zajicek; Dawn Fischer; Aimee Jackson
Journal:  Am J Obstet Gynecol       Date:  2012-08-16       Impact factor: 8.661

Review 8.  Antihistamines and birth defects: a systematic review of the literature.

Authors:  Suzanne M Gilboa; Elizabeth C Ailes; Ramona P Rai; Jaynia A Anderson; Margaret A Honein
Journal:  Expert Opin Drug Saf       Date:  2014-10-11       Impact factor: 4.250

9.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

10.  EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.

Authors:  Joanne E Given; Maria Loane; Johannes M Luteijn; Joan K Morris; Lolkje T W de Jong van den Berg; Ester Garne; Marie-Claude Addor; Ingeborg Barisic; Hermien de Walle; Miriam Gatt; Kari Klungsoyr; Babak Khoshnood; Anna Latos-Bielenska; Vera Nelen; Amanda J Neville; Mary O'Mahony; Anna Pierini; David Tucker; Awi Wiesel; Helen Dolk
Journal:  Br J Clin Pharmacol       Date:  2016-07-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.